| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |